Our Mission
PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
Tag Archives for " Liver Cancer "
Sorafenib for Liver Cancer- Integrate?
Sorafenib is a multikinase inhibitor used for the treatment of uHCC 10 Two Phase III studies (SHARP and Asia-Pacific) demonstrated significant improvements in overall survival in Hepatocellular Carcinoma
Continue readingLiver Cancer- Burzynski Research Institute (BRI), Antineoplaston Therapy (ANP)
“These results suggested that antineoplaston A10 may inhibit the growth of human hepatoma cells through the induction of apoptosis” Conventional oncology may have little to offer the liver
Continue reading